Animal Behavioral Test Service

Animal behavioral testing is a critical component of preclinical research, serving to evaluate the functional impact of candidate anticancer drugs or therapeutics on the central nervous system and overall behavioral status. Alfa Cytology provides comprehensive animal behavioral testing services, encompassing learning and memory function assessments, motor function and muscle strength evaluations, emotional status and anxiety/depression-like behavior analyses, as well as social behavior and special environmental intervention studies, to support your oncology drug development programs.

Introduction to Animal Behavioral Test

Behavioral testing serves as a critical bridge connecting molecular and pathological findings with whole-animal functional outcomes, providing integrative information in oncology drug development that cannot be obtained from molecular lysates or tissue sections alone. Through systematic behavioral assessments, researchers can quantitatively evaluate drug effects on cognitive function, motor coordination, emotional status, and social ability, generating key functional evidence for chemotherapy-induced peripheral neuropathy (CIPN), "chemo-brain"-related cognitive impairment, cancer cachexia-associated muscle dysfunction, and immunotherapy-related neuropsychiatric side effects. These data directly support neurotoxicity safety evaluation, pharmacodynamic assessment, and combination strategy optimization, providing indispensable behavioral evidence for dose selection and risk mitigation, ultimately facilitating the translation of oncology therapeutics from preclinical research to clinical development.

Fig. 1 Tracking the trajectory of the head and tail base of mice in the Y-maze. (Kim J, et al.; 2023)

Our Services

Alfa Cytology offers a comprehensive suite of animal behavioral test services designed to assess the functional impact of drug candidates on cognitive function, motor coordination, emotional status, and social behavior in preclinical oncology models.

Our assays are specifically tailored to address key neurobehavioral challenges associated with anticancer therapies, including chemotherapy-induced cognitive impairment ("chemo-brain"), peripheral neuropathy, cancer cachexia-related muscle dysfunction, and immunotherapy-associated psychiatric side effects. By integrating automated tracking systems and standardized protocols, we deliver objective, quantitative, and reproducible data to support neuro-safety evaluation, pharmacodynamic assessment, and combination strategy optimization.

Test Types

Learning and Memory Function Assessment

Evaluates drug effects on spatial memory, working memory, and recognition memory, primarily applicable to chemotherapy-induced cognitive impairment ("chemo-brain"), cognitive deficits associated with cranial radiotherapy, and neuro-safety evaluation of central nervous system (CNS)-penetrant agents.

Morris Water Maze

A classic paradigm for assessing spatial learning and memory by recording the animal's swim path, escape latency, and strategy shifts in locating a hidden platform within a circular pool, evaluating hippocampus-dependent spatial memory function. Used to detect learning and memory impairments induced by chemotherapeutic agents or cranial irradiation.

Y-Maze Spontaneous Alternation Test

Leverages the innate exploratory tendency of rodents toward novel environments by recording the sequence of arm entries across three arms and calculating the spontaneous alternation rate, assessing short-term spatial working memory mediated by the hippocampal-prefrontal cortex circuit. This test requires no reward or punishment, has a short testing duration, and is particularly suitable for rapid screening of working memory deficits in "chemo-brain" models and preliminary evaluation of neuroprotective efficacy.

Novel Object Recognition Test

Evaluates non-spatial recognition memory by measuring the ratio of exploration time between a novel object and a familiar object, assessing drug effects on recognition memory. Applicable to the evaluation of cortical-dependent cognitive function.

Shuttle Avoidance / Step-through Test

Assesses passive avoidance memory and active learning ability by combining electrical shock with conditioned stimuli, recording avoidance response rate and latency. Used to evaluate drug effects on associative learning and memory consolidation functions.

Motor Function and Muscle Strength Assessment

Evaluates drug effects on motor coordination, balance, muscle strength, and endurance, applicable to chemotherapy-induced peripheral neuropathy (CIPN), cancer cachexia-associated muscle atrophy, and neuromuscular toxicity assessment.

Gait Analysis

Quantitatively assesses gait parameters during locomotion, including stride length, step width, stance phase, swing phase, and paw print area. Used to detect drug-induced motor coordination deficits, peripheral neuropathy, and analgesic efficacy, particularly suitable for evaluating peripheral neurotoxicity induced by chemotherapeutic agents such as paclitaxel and oxaliplatin.

Grip Strength Test

Utilizes a grip strength meter to quantitatively measure forelimb and hindlimb grip strength, assessing muscle strength and neuromuscular function. Applied in cancer cachexia models for muscle atrophy evaluation and neuromuscular toxicity monitoring.

Rotarod Test

Evaluates motor coordination and balance function by recording the animal's latency to fall and rotational speed on a rotating rod, assessing drug effects on cerebellar and basal ganglia function.

Treadmill Exercise Test

Employs a motorized treadmill for exercise training or exhaustive testing, evaluating exercise endurance and cardiorespiratory function. Used for muscle function assessment and exercise intervention strategy studies in cancer cachexia models.

Emotional Status and Anxiety/Depression-Like Behavior Assessment

Evaluates drug effects on affective states, applicable to the assessment of psychiatric side effects associated with immunotherapies and the potential impact of anticancer agents on emotional regulation centers.

Open Field Test

Assesses spontaneous locomotor activity and anxiety-like behavior. An automated tracking system records total distance traveled, activity time, central zone entries, and central zone duration in an open arena, reflecting drug effects on motor activity and emotional status.

Elevated Plus Maze

A classic paradigm for anxiety-like behavior assessment. Leveraging the conflict between the innate exploratory drive toward novel environments and the aversion to open, elevated arms, this test evaluates anxiolytic or anxiogenic effects by recording the number of entries and time spent in open versus closed arms.

Tail Suspension Test

Evaluates depression-like behavior by recording the duration of immobility during suspension. Used in conjunction with the forced swim test as complementary assays to detect potential depression-inducing effects or antidepressant activity of drug candidates.

Forced Swim Test

Assesses depression-like behavior and despair state by recording the duration of immobility in an inescapable water chamber. Used to evaluate drug effects on emotional status, particularly suitable for assessing depression-like side effects associated with immunotherapies.

Social Behavior and Special Environmental Intervention Assessment

Evaluates drug effects on social ability and memory, as well as behavioral and physiological adaptation under specialized environmental conditions. Supports assessment of immunotherapy-related neuropsychiatric side effects, tumor microenvironment modulation, and adjunctive therapeutic strategies.

Three-Chamber Social Test

Evaluates sociability and social memory by recording preference for social stimuli versus inanimate objects, and novel versus familiar conspecifics. Used to detect drug-induced social behavior changes, particularly for immunotherapy-related neuropsychiatric side effects.

Hyperbaric Oxygen Chamber

Provides controllable normobaric/hyperbaric oxygen environments to simulate hyperoxic or hypoxic conditions. Used to study hypoxia effects on tumor progression, neuroprotective efficacy of hyperbaric oxygen, and physiological/behavioral adaptations under pharmacological interventions.

Supported Therapeutic Modalities

Our animal behavioral test services support a broad spectrum of cancer therapeutic modalities, providing critical functional data for neuro-safety evaluation, side effect assessment, and efficacy validation across diverse treatment approaches.

Small Molecule	Therapeutic Antibody	Cell Therapy	Gene Therapy
Cancer Vaccine	Peptide Therapy	Nucleic Acid Therapeutics	Oncolytic Viral Therapy

Available Model Systems

• Tumor Models: CDX/PDX tumor-bearing mice, orthotopic tumor models, brain metastasis models, cancer cachexia models, chemotherapy-induced peripheral neuropathy (CIPN) models
• Behavioral Assessment Models: Cognitive impairment models ("chemo-brain"/CICI models), depression/anxiety models, motor dysfunction models, pain models

Applications of Our Animal Behavioral Test Service

Alfa Cytology offers flexible animal behavioral testing service packages tailored to your program needs. All our behavioral assay solutions are designed around the specific requirements of oncology drug development, covering major therapeutic modalities including chemotherapy, immunotherapy, and targeted therapy. If you are interested in learning how our animal behavioral testing services can accelerate your oncology drug development programs, please don't hesitate to contact us.

For research use only.